Previous years 4

2022 - 07 - 26 1 2022 - 06 - 13 1 2022 - 01 - 19 1 2021 - 10 - 29 1

Health technology 4

Agreement 2 Alliances 3 Antibody 3 Application 4 Approval 10 Approved 4 Australia 4 Authorization 24 Authorized 5 Awards 3 Biocapital 29 Biopharma 3 Bioscience 2 Biotech 2 Biotechnology 22 Canada 3 Candidate 2 Chmp 3 Clinical-trials-phase-ii 3 Clinical-trials-phase-iii 4 Conference 26 Congress 2 Covid 67 Covid-19 93 Deadline 5 Disease 7 Earnings 6 Emergency use authorization 10 Europe 9 Events 9 Fda 11 Financial 10 Financial results 7 Global 3 Grant 5 Granted 8 Grants 3 Health 7 India 10 Influenza 7 License 3 Merge 9 N/a 131 Nuvaxovid 3 Nvx-cov2373 5 Offering 6 People 4 Phase 2 5 Phase 2b 3 Phase 3 13 Positive 6 Product-news 3 Prototype 5 Research 10 Results 27 Submission 5 Switzerland 3 Trial 20 Vaccine 132 World 3

Novavax, inc. 4

ABVC 3 ACM 5 AKBA 2 AMCR 2 AMRN 2 ARVL 10 ATHE 7 ATNF 2 AVHHL 3 BNOX 2 BW 3 BYNO 4 CLVR 2 CMRX 2 COP 2 CRCW 3 CSIQ 4 CYTO 2 DCT 2 DEO 4 DGEAF 4 DKILF 2 DKILY 2 EBON 2 ENPH 3 EOLS 2 EQIX 3 EVOTF 9 EXPR 4 FCN 4 FLNC 4 FNCTF 9 FTCI 2 FUTU 3 GENE 8 HEPA 2 IESC 2 IHLXF 2 IMMP 19 IMRN 6 INBS 3 INCY 5 IXHL 5 KZIA 12 LLY 5 MGNI 9 MKL 3 NSRPF 4 NVAX 4 OPT 8 PPCB 21 SNY 8 SNYNF 8 SPI 3 STZ 4 TRUMF 3 TRUMY 3 VSAC 5 WFAFF 3 WFAFY 3

Nasdaq 4

2022 - 07 - 26 1 2022 - 06 - 13 1 2022 - 01 - 20 1 2021 - 10 - 29 1

01:00 1 12:00 2 12:20 1

www.biospace.com 3 www.prnewswire.com 1